 REDWOOD CITY, Calif., April 30, 2021 GLOBE NEWSWIRE -- Coherus BioSciences, Inc. Coherus or the Company, Nasdaq: CHRS, today announced that effective April 28, 2021, the compensation committee of the Companys board of directors granted options to purchase an aggregate of 483,000 shares of the common stock of the Company to newly hired employees with a per share exercise price of 14.76, the closing trading price on the grant date. A newly hired Executive Vice President was granted an option to buy 125,000 shares; two Senior Vice Presidents were each granted an option to buy 100,000 shares; a Vice President was granted an option to buy 50,000 shares; a Vice President was granted an option to buy 45,000 shares; eight additional non-officer employees were granted options to buy an aggregate of 63,000 shares. 